Trial Profile
Enoxaparin sodium +/- edoxaban vs edoxaban alone in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Aug 2012
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Enoxaparin sodium
- Indications Deep vein thrombosis; Embolism; Myocardial infarction; Small cell lung cancer; Stroke; Thromboembolism; Unstable angina pectoris; Venous thromboembolism
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 01 Aug 2012 New trial record